NO970784L - Fremgangsmåte for opprettholdelse av tenner og oralt ben - Google Patents
Fremgangsmåte for opprettholdelse av tenner og oralt benInfo
- Publication number
- NO970784L NO970784L NO970784A NO970784A NO970784L NO 970784 L NO970784 L NO 970784L NO 970784 A NO970784 A NO 970784A NO 970784 A NO970784 A NO 970784A NO 970784 L NO970784 L NO 970784L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- oral bone
- maintaining teeth
- teeth
- maintaining
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Fremgangsmåte for opprettholdelse av tenner og oralt ben, omfattende administrering til et menneske som trenger dette, en effektiv mengde av en forbindelse med formel (1) OCHjCHj-rJ R^O' 0) hvor R^ og r3 uavhengig er hydrogen, -CH3, (a) eller (b), hvor Ar eventuelt er substituert fenyl; R^ er valgt fra gruppen omfattende pyrrolidon, heksametylenimino og piperidino; eller et farmasøytisk akseptabelt salt eller solvat derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29423794A | 1994-08-22 | 1994-08-22 | |
PCT/US1995/010582 WO1996005829A1 (en) | 1994-08-22 | 1995-08-21 | Methods of maintaining teeth and oral bone |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970784L true NO970784L (no) | 1997-02-20 |
NO970784D0 NO970784D0 (no) | 1997-02-20 |
Family
ID=23132491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970784A NO970784D0 (no) | 1994-08-22 | 1997-02-20 | Fremgangsmåte for opprettholdelse av tenner og oralt ben |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0769946A4 (no) |
JP (1) | JPH10504573A (no) |
KR (1) | KR970705386A (no) |
AU (1) | AU692598B2 (no) |
CA (1) | CA2198108A1 (no) |
CZ (1) | CZ52197A3 (no) |
FI (1) | FI970713A0 (no) |
HU (1) | HUT76891A (no) |
IL (1) | IL115017A0 (no) |
MX (1) | MX9701331A (no) |
NO (1) | NO970784D0 (no) |
WO (1) | WO1996005829A1 (no) |
YU (1) | YU55495A (no) |
ZA (1) | ZA956987B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
-
1995
- 1995-08-21 WO PCT/US1995/010582 patent/WO1996005829A1/en not_active Application Discontinuation
- 1995-08-21 YU YU55495A patent/YU55495A/sh unknown
- 1995-08-21 KR KR1019970701096A patent/KR970705386A/ko not_active Application Discontinuation
- 1995-08-21 CZ CZ97521A patent/CZ52197A3/cs unknown
- 1995-08-21 EP EP95930864A patent/EP0769946A4/en not_active Ceased
- 1995-08-21 CA CA002198108A patent/CA2198108A1/en not_active Abandoned
- 1995-08-21 ZA ZA9506987A patent/ZA956987B/xx unknown
- 1995-08-21 MX MX9701331A patent/MX9701331A/es unknown
- 1995-08-21 AU AU34088/95A patent/AU692598B2/en not_active Ceased
- 1995-08-21 HU HU9701352A patent/HUT76891A/hu unknown
- 1995-08-21 JP JP8508232A patent/JPH10504573A/ja active Pending
- 1995-08-21 IL IL11501795A patent/IL115017A0/xx unknown
-
1997
- 1997-02-20 NO NO970784A patent/NO970784D0/no unknown
- 1997-02-20 FI FI970713A patent/FI970713A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
YU55495A (sh) | 1998-07-10 |
ZA956987B (en) | 1997-02-21 |
IL115017A0 (en) | 1995-12-08 |
CA2198108A1 (en) | 1996-02-29 |
AU3408895A (en) | 1996-03-14 |
KR970705386A (ko) | 1997-10-09 |
CZ52197A3 (en) | 1997-08-13 |
EP0769946A1 (en) | 1997-05-02 |
FI970713A (fi) | 1997-02-20 |
WO1996005829A1 (en) | 1996-02-29 |
HUT76891A (en) | 1997-12-29 |
AU692598B2 (en) | 1998-06-11 |
JPH10504573A (ja) | 1998-05-06 |
EP0769946A4 (en) | 1997-11-05 |
MX9701331A (es) | 1997-05-31 |
FI970713A0 (fi) | 1997-02-20 |
NO970784D0 (no) | 1997-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111288A (en) | Uses of 2-phenyl-3-aroylbenzothiophenes and 3-phenyl-4-aroyl-1,2-dihydronaphthalenes for the preparation of a medicament for inhibiting smooth muscle cell proliferation and restinosis | |
NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
HUT71344A (en) | Pharmaceutical compositions for inhibiting thrombin containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation | |
IL111284A (en) | 2-phenyl-3-aroylbenzothiophenes for use as medicaments for inhibiting endometriosis | |
DK0771200T3 (da) | Anvendelse af raloxifen og dets analoger til fremstilling af et medikament til behandling af virale sygdomme | |
DK0651999T3 (da) | Fremgangsmåder til inhibering af livmoderfibrose | |
DK0652000T3 (da) | Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme | |
MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
DK0652002T3 (da) | Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning | |
NO970786L (no) | Fremgangsmåte for hemming av benprotesedegradering | |
GB9108629D0 (en) | Heterocyclic pharmaceutical compounds,preparation and use | |
NO970784L (no) | Fremgangsmåte for opprettholdelse av tenner og oralt ben | |
NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin | |
DK0769945T3 (da) | Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud | |
NO971029L (no) | Fremgangsmåter for hemming av endometriale metoser | |
NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter | |
DK0771201T3 (da) | Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi | |
MX9709536A (es) | Metodo para reducir el factor de transcripcion bef-1. |